SciDevL (SDV) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
23 Nov, 2025Executive summary
FY 2025 revenue was $103 million, with underlying EBITDA of $7.1 million and operating cash flow of $2.9 million, reflecting a year of strategic investment and international expansion.
Focused on building a diversified, globally significant portfolio in water solutions, with two main segments: chemical services and water technologies.
Expanded operational footprint in North America, Asia-Pacific, and Europe, with significant growth in proprietary technology sales and new PFAS treatment contracts.
Strategic priorities included market share growth, margin expansion, and pivoting to higher-margin proprietary products.
Strengthened board and reinvested in business development to support sustained growth.
Financial highlights
Revenue for FY 2025 was $103 million, down from $109 million in FY 2024, mainly due to a 26% contraction in water technologies revenue.
Gross margin improved by 2 percentage points to 28%, reflecting a shift to higher-margin proprietary products.
Underlying EBITDA was $7.1 million, 19% lower than FY 2024, due to reinvestment in growth initiatives.
Net loss after tax was $900,000, impacted by higher tax expense and project challenges.
Positive operating cash flow of $2.9 million, with 90% EBITDA cash conversion.
Closing cash position was $9.7 million, with $3.5 million in debt.
Outlook and guidance
Positioned for meaningful growth in FY 2026, leveraging a robust pipeline and backlog.
Focus on converting delayed contracts and returning water technologies to profitability.
Continued international expansion, especially in U.S. shale gas and European PFAS markets.
Europe expected to achieve EBITDA break-even in FY 2026.
Anticipates medium-term upside from rising US shale gas production despite near-term oil & gas headwinds.
Latest events from SciDevL
- Revenue and EBITDA declined, but recurring revenue and cost actions support future growth.SDV
H1 202625 Feb 2026 - EBITDA rose to $3.4m on steady $49.9m revenue, with strong cash and PFAS-driven growth outlook.SDV
H1 202526 Dec 2025 - Revenue and EBITDA surged, with strategic US wins and strong demand despite market volatility.SDV
Q3 2025 TU16 Jun 2025 - FY24 saw double-digit growth and strategic expansion in water, mining, and PFAS solutions.SDV
AGM 2024 Presentation13 Jun 2025 - Q1 FY25 saw 21% revenue growth, 286% EBITDA increase, and robust cash flow.SDV
Q1 2025 TU13 Jun 2025 - Record revenue, profit, and cash flow position SciDev for continued growth in FY25.SDV
H2 202413 Jun 2025 - Record revenue and EBITDA growth driven by PFAS demand and major contract wins.SDV
Q4 2024 TU13 Jun 2025